Skip to main content

Peer Review reports

From: Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

Original Submission
22 Jan 2017 Submitted Original manuscript
13 Mar 2017 Reviewed Reviewer Report - Seungtaek Choi
20 Mar 2017 Reviewed Reviewer Report - Jennifer Beebe-Dimmer
10 Apr 2017 Author responded Author comments - Yong Jin Kang
Resubmission - Version 2
10 Apr 2017 Submitted Manuscript version 2
20 Jul 2017 Reviewed Reviewer Report - Jennifer Beebe-Dimmer
21 Jul 2017 Reviewed Reviewer Report - Seungtaek Choi
12 Sep 2017 Author responded Author comments - Yong Jin Kang
Resubmission - Version 3
12 Sep 2017 Submitted Manuscript version 3
2 Oct 2017 Author responded Author comments - Yong Jin Kang
Resubmission - Version 4
2 Oct 2017 Submitted Manuscript version 4
4 Nov 2017 Author responded Author comments - Yong Jin Kang
Resubmission - Version 5
4 Nov 2017 Submitted Manuscript version 5
Publishing
13 Nov 2017 Editorially accepted
23 Nov 2017 Article published 10.1186/s12885-017-3775-6

You can find further information about peer review here.

Back to article page